niacinamide has been researched along with Thrombotic Microangiopathies in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Thrombotic Microangiopathies: Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recently, cancer therapies have been supplemented by vascular endothelial growth factor (VEGF) inhibitors as anti-angiogenic agents." | 2.50 | Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature. ( Chandran, CB; Flombaum, CD; Glezerman, IG; Salvatore, SP; Seshan, SV; Usui, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izzedine, H | 1 |
| Mangier, M | 1 |
| Ory, V | 1 |
| Zhang, SY | 1 |
| Sendeyo, K | 1 |
| Bouachi, K | 1 |
| Audard, V | 1 |
| Péchoux, C | 1 |
| Soria, JC | 1 |
| Massard, C | 1 |
| Bahleda, R | 1 |
| Bourry, E | 1 |
| Khayat, D | 1 |
| Baumelou, A | 1 |
| Lang, P | 1 |
| Ollero, M | 1 |
| Pawlak, A | 1 |
| Sahali, D | 1 |
| Usui, J | 1 |
| Glezerman, IG | 1 |
| Salvatore, SP | 1 |
| Chandran, CB | 1 |
| Flombaum, CD | 1 |
| Seshan, SV | 1 |
| Yılmaz, S | 1 |
| Özçakar, ZB | 1 |
| Taktak, A | 1 |
| Kiremitçi, S | 1 |
| Ensari, A | 1 |
| Dinçaslan, H | 1 |
| Yalçınkaya, F | 1 |
1 review available for niacinamide and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
Topics: Acute Kidney Injury; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplasti | 2014 |
2 other studies available for niacinamide and Thrombotic Microangiopathies
| Article | Year |
|---|---|
Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Angiogenesis Inhibitors; Animals; Base Sequence; | 2014 |
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2016 |